ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2021

The Association Between Rheumatoid Factor and Cardiovascular Disease in Healthy Adults

Chisun Min1, Mitsumasa Kishimoto1, Gautam A. Deshpande2, Shunya Kaneshita1, Masei Suda1, Yuri Ohara1, Yoichiro Haji1, Ryo Rokutanda1, Yasuhiro Suyama1, Hisanori Shimizu1, Tokutaro Tsuda1, Ken-ichi Yamaguchi1, Akira Takeda3, Yukio Matsui1 and Masato Okada1, 1Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan, 2Center for Clinical Epidemiology, St. Luke's Life Science Instutute, Tokyo, Japan, 3Division of Clinical Immunology & Rheumatology, International University of Health and Welfare Hospital, Nasu-shiobara, Japan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease and rheumatoid arthritis (RA), Rheumatoid Factor

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Public Health (ACR): Rheumatoid Arthritis Pathogenesis and Treatment

Session Type: Abstract Submissions (ACR)

Background/Purpose

Rheumatoid arthritis (RA) has been shown to be a risk factor for cardiovascular disease (CVD). Both elevated rheumatoid factor (RF) and anti-citrullinated protein antibodies have been reported to be associated with substantially higher risk of CVD and mortality among RA patients. However, the correlation between RF and CVD in the general population remains unclear. This study examines whether RF is associated with CVD in apparently healthy individuals.

Methods

All participants presenting to the Center for Preventive Medicine at St. Luke’s International Hospital in Tokyo, Japan from April 2004 to March 2013 for an annual health screening were included in this retrospective, cross-sectional study. The goals of this employer-mandated screening program are early detection of chronic disease and identification of risk factors. In addition to various CVD risk factors, RF is also routinely measured for early detection of rheumatoid arthritis.

Participants were divided into two groups by the presence of self-reported CVD. Using this as the primary outcome, we compared several parameters including RF positivity (>15 IU/ml), age, male gender, height, weight, body-mass index (BMI), waist circumference (WC), body fat percentage, systolic blood pressure (SBP), diastolic blood pressure (DBP), lipid profile, HbA1c, fasting blood glucose (FBG), uric acid (UA), C-reactive protein (CRP), percentage of ever-smokers and ever-drinkers, presence of self-reported CVD risk factors including dyslipidemia (DL), diabetes mellitus (DM) and hypertension (HTN), and family history of CVD. We evaluated whether whether RF positivity was independently associated with CVD using multivariate regression analysis.

Results

Of 111,021 individuals presenting for health checkup during the study period, 110,856 (99.9%) provided complete datasets regarding our parameters of interests. Of these, mean age was 46.0±12.0 (48.9% men) and 1,863 (1.7%) reported a history of CVD.

On univariate analysis, individuals with CVD were more likely to be male (70 vs. 48.5%), older (62.7 vs. 45.8 years), and have RF positivity (12.4 vs. 8.9%). Those with CVD also had poorer metabolic markers including BMI (23.7 vs. 22.3), WC (85.3 vs. 79.9cm), SBP (128 vs. 117mmHg), DBP (77.9 vs. 72.3mmHg), cholesterol ratio (3.7 vs. 3.4), HbA1c (5.9 vs. 5.5%), FBG (108 vs. 99mg/dl), CRP (0.19 vs. 0.12mg/dl). Health history was also suboptimal in the CVD group, including ever-smoking (57.8 vs. 40.0%); history of CVD risk factors such as DL, DM and HTN (22.3 vs. 4.4%, 2.4 vs. 0.3% and 35.9 vs. 7.1%, respectively); and family CVD history (37.1 vs. 22.2%). p-value < 0.001 for all.

On multivariate analysis, however, RF positivity was not correlated with CVD (1.06, 95%CI 0.91-1.22), in either men (1.03, 95%CI 0.85-1.23) or women (1.10, 95%CI 0.86-1.42) after adjustment for clinically established risk factors.

Conclusion

Despite its association with CVD in individuals with RA, RF does not appear to be correlated with CVD and appears to be inappropriate for use as a CVD screening test in apparently healthy individuals. Further investigations to clarify the reason for this discrepancy between RA patients and general population are warranted in the future.


Disclosure:

C. Min,
None;

M. Kishimoto,
None;

G. A. Deshpande,
None;

S. Kaneshita,
None;

M. Suda,
None;

Y. Ohara,
None;

Y. Haji,
None;

R. Rokutanda,
None;

Y. Suyama,
None;

H. Shimizu,
None;

T. Tsuda,
None;

K. I. Yamaguchi,
None;

A. Takeda,
None;

Y. Matsui,
None;

M. Okada,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-association-between-rheumatoid-factor-and-cardiovascular-disease-in-healthy-adults/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology